The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19)
The article describes a clinical case of vaccination with the drug "Kovivac" of a patient of an older age group with an established diagnosis of bullous pemphigoid. Scientific data on the prevalence of bullous dermatoses in the Russian Federation (true pemphigus, Lever's bullous pemph...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2021-10-01
|
| Series: | Vestnik Dermatologii i Venerologii |
| Subjects: | |
| Online Access: | https://vestnikdv.ru/jour/article/viewFile/1244/1221 |
| _version_ | 1797720114313822208 |
|---|---|
| author | Andrey A. Martynov Anna V. Vlasova |
| author_facet | Andrey A. Martynov Anna V. Vlasova |
| author_sort | Andrey A. Martynov |
| collection | DOAJ |
| description | The article describes a clinical case of vaccination with the drug "Kovivac" of a patient of an older age group with an established diagnosis of bullous pemphigoid. Scientific data on the prevalence of bullous dermatoses in the Russian Federation (true pemphigus, Lever's bullous pemphigoid, Dhring's herpetiformis dermatitis) are presented. There is a good tolerance of the Kovivac vaccine in a patient suffering from bullous pemphigoid, which allows vaccination, in fact, without interrupting patients from their daily activities and without diverting the resources of the healthcare system to unreasonable inpatient care. The decision to vaccinate should be made on the basis of data on the available indications / contraindications for drugs, taking into account the individual anamnestic data of patients. In addition, it should be borne in mind that until now, all links of the infectious process caused by SARS-CoV-2 have not been fully studied. In this regard, before vaccination, patients must be informed of the need to comply with the anti-epidemic measures recommended for the prevention of coronavirus infection (COVID-19), even after full vaccination, as well as dynamic observation by specialist doctors. |
| first_indexed | 2024-03-12T09:15:50Z |
| format | Article |
| id | doaj.art-47714a7bc49b4368a01a2093988f20b5 |
| institution | Directory Open Access Journal |
| issn | 0042-4609 2313-6294 |
| language | English |
| last_indexed | 2024-03-12T09:15:50Z |
| publishDate | 2021-10-01 |
| publisher | State Scientific Center of Dermatovenereology and Cosmetology |
| record_format | Article |
| series | Vestnik Dermatologii i Venerologii |
| spelling | doaj.art-47714a7bc49b4368a01a2093988f20b52023-09-02T14:50:34ZengState Scientific Center of Dermatovenereology and CosmetologyVestnik Dermatologii i Venerologii0042-46092313-62942021-10-0197410711210.25208/vdv12441115The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19)Andrey A. Martynov0https://orcid.org/0000-0002-5756-2747Anna V. Vlasova1https://orcid.org/0000-0002-7677-1544State Research Center of Dermatovenereology and CosmetologySechenov UniversityThe article describes a clinical case of vaccination with the drug "Kovivac" of a patient of an older age group with an established diagnosis of bullous pemphigoid. Scientific data on the prevalence of bullous dermatoses in the Russian Federation (true pemphigus, Lever's bullous pemphigoid, Dhring's herpetiformis dermatitis) are presented. There is a good tolerance of the Kovivac vaccine in a patient suffering from bullous pemphigoid, which allows vaccination, in fact, without interrupting patients from their daily activities and without diverting the resources of the healthcare system to unreasonable inpatient care. The decision to vaccinate should be made on the basis of data on the available indications / contraindications for drugs, taking into account the individual anamnestic data of patients. In addition, it should be borne in mind that until now, all links of the infectious process caused by SARS-CoV-2 have not been fully studied. In this regard, before vaccination, patients must be informed of the need to comply with the anti-epidemic measures recommended for the prevention of coronavirus infection (COVID-19), even after full vaccination, as well as dynamic observation by specialist doctors.https://vestnikdv.ru/jour/article/viewFile/1244/1221novel coronavirus infection (covid-19)bullous pemphigoidvaccination against covid-19vaccine kovivacbullous dermatosestrue pemphigusdühring's dermatitis herpetiformis |
| spellingShingle | Andrey A. Martynov Anna V. Vlasova The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19) Vestnik Dermatologii i Venerologii novel coronavirus infection (covid-19) bullous pemphigoid vaccination against covid-19 vaccine kovivac bullous dermatoses true pemphigus dühring's dermatitis herpetiformis |
| title | The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19) |
| title_full | The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19) |
| title_fullStr | The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19) |
| title_full_unstemmed | The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19) |
| title_short | The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19) |
| title_sort | course of bullous pemphigoid against the background of vaccination against a new coronavirus infection covid 19 |
| topic | novel coronavirus infection (covid-19) bullous pemphigoid vaccination against covid-19 vaccine kovivac bullous dermatoses true pemphigus dühring's dermatitis herpetiformis |
| url | https://vestnikdv.ru/jour/article/viewFile/1244/1221 |
| work_keys_str_mv | AT andreyamartynov thecourseofbullouspemphigoidagainstthebackgroundofvaccinationagainstanewcoronavirusinfectioncovid19 AT annavvlasova thecourseofbullouspemphigoidagainstthebackgroundofvaccinationagainstanewcoronavirusinfectioncovid19 AT andreyamartynov courseofbullouspemphigoidagainstthebackgroundofvaccinationagainstanewcoronavirusinfectioncovid19 AT annavvlasova courseofbullouspemphigoidagainstthebackgroundofvaccinationagainstanewcoronavirusinfectioncovid19 |